2004
DOI: 10.1007/s10517-004-0030-3
|View full text |Cite
|
Sign up to set email alerts
|

Hereditary muscular dystrophy in MDX mice as a homologous model for introduction of cell technologies in the treatment of progressive muscular dystrophies in humans

Abstract: Life-time monitoring of the main clinical and laboratory manifestations of hereditary muscular dystrophy in mdx mice confirmed the presence of mutation in exon 23 of dystrophin gene and the absence of this protein in skeletal muscles of mutant animals. Muscular dystrophy in mice was similar to human progressive muscle disorder, which allows the use of this model for the development of cell technologies for the treatment of hereditary muscular diseases in humans.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…These mice were a part of the reproductive colony maintained at Russian State Medical University [2]. ECG in standard lead II was recorded on nonanesthesized alert animals in natural (abdominal) posture with the limbs slightly fixed to the platform.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…These mice were a part of the reproductive colony maintained at Russian State Medical University [2]. ECG in standard lead II was recorded on nonanesthesized alert animals in natural (abdominal) posture with the limbs slightly fixed to the platform.…”
Section: Methodsmentioning
confidence: 99%
“…Activity of creatine kinase (CPK) was measured in blood samples collected from the caudal vein as described previously [2].…”
Section: Methodsmentioning
confidence: 99%